|
The Industry Benchmarking Committee oversees and manages the Center’s industry benchmarking program, which is used to develop our annual HDMA Factbook.
The HDMA Factbook is considered one of the best industry reference books, providing benchmarks for performance and trends in the evolving healthcare industry. Companies that contribute data as part of the benchmarking program receive complementary copies of the Factbook and customized data reports.
Committee Objectives
- Develop comprehensive benchmarking surveys for healthcare distributors and manufacturers;
- Review and validate aggregated benchmarking results to ensure accuracy; and
- Oversee content development and production of the HDMA Factbook.
2010-2011 Committee Roster:
Chairman
Joseph Perri
Regional Director of Finance, East Region
AmerisourceBergen Drug Co.
Rhonda Bajenski
Director, Financial Planning & Analysis HSCS
Cardinal Health, Inc.
John Baranick
Senior Account Director, Trade Sales
AstraZeneca Pharmaceuticals
Anne Faul
Director, Pharmacy Stratey & Analysis
GlaxoSmithKline
Sean Henderson
Senior Finance Director
McKesson Supply Solutions
Chris Holland
Director, Operations
Oncology Therapeutics Network (OTN)
Douglas M. Long
Vice President, Industry Relations
IMS HEALTH
James F. Meehan
Vice President, Sales & Distribution
Ranbaxy Pharmaceuticals, Inc.
Daniel M. Moore
Vice President, Distribution Center Manager
AmerisourceBergen Drug Company
Robert I. Sanderson
National Account Director
Greenstone LLC
Ed Vianco
Vice President, Controller
McKesson Corp.
John Voss
Corporate Controller
H.D. Smith
Staff Liaison
Susan Heffner
Director, Research & Information Services
Center for Healthcare Supply Chain Research
Anti-trust Policy
Anti-harassment Policy
|
